Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 08-Aug-19 4:23 PM View:  | Reshape Lifesciences Inc. (OBLN) | 06-Aug-19 | Purchase | 250,000 | $4.00 | $1,000,000.00 | 44% 563.43K to 813.43K | |
| 27-Aug-18 5:32 PM View: | Reshape Lifesciences Inc. (OBLN) | 23-Aug-18 | Private Purchase | 1,648,360 | $1.82 | $3,000,010.00 | 41% 3.99M to 5.63M | |
| 03-Nov-16 9:47 PM View: | Tobira Therapeutics, Inc. (TBRA) | 01-Nov-16 | Disposition (change in control) | 3,553,320 | $28.35 | $100,737,000.00 | (100%) 3.55M to 0 | |
| 14-Oct-16 11:58 AM View: | Reshape Lifesciences Inc. (OBLN) | 12-Oct-16 | Conversion | 3,985,970 | -- | -- | 100% 0 to 3.99M | |
| 27-May-16 5:20 PM View: | Evoke Pharma Inc (EVOK) | 26-May-16 | Sale | 344,120 | $4.70 | $1,617,360.00 | (36%) 950.4K to 606.28K | |
| 27-Apr-16 8:25 PM View: | Evoke Pharma Inc (EVOK) | 27-Apr-16 | Market Sale | 3,603 | $5.02 | $18,087.10 | (< 1%) 954.01K to 950.4K | 47% |
| 27-Apr-16 8:25 PM View: | Evoke Pharma Inc (EVOK) | 25-Apr-16 | Market Sale | 1,492 | $5.20 | $7,758.40 | (< 1%) 955.5K to 954.01K | 49% |
| 21-Apr-16 4:57 PM View: | Evoke Pharma Inc (EVOK) | 20-Apr-16 | Market Sale | 4,424 | $5.29 | $23,403.00 | (< 1%) 959.92K to 955.5K | 50% |
| 21-Apr-16 4:57 PM View: | Evoke Pharma Inc (EVOK) | 19-Apr-16 | Market Sale | 37,054 | $5.36 | $198,609.00 | (4%) 996.98K to 959.92K | 51% |
| 13-Apr-16 7:27 PM View: | Evoke Pharma Inc (EVOK) | 11-Apr-16 | Market Sale | 4,348 | $5.22 | $22,696.60 | (< 1%) 1.0M to 996.98K | 49% |
| 08-Apr-16 8:49 PM View: | Evoke Pharma Inc (EVOK) | 08-Apr-16 | Market Sale | 14,554 | $5.35 | $77,863.90 | (1%) 1.02M to 1.0M | 51% |
| 08-Apr-16 8:49 PM View: | Evoke Pharma Inc (EVOK) | 07-Apr-16 | Market Sale | 27,781 | $5.26 | $146,128.00 | (3%) 1.04M to 1.02M | 50% |
| 08-Apr-16 8:49 PM View: | Evoke Pharma Inc (EVOK) | 06-Apr-16 | Market Sale | 8,669 | $5.22 | $45,252.20 | (< 1%) 1.05M to 1.04M | 49% |
| 20-Aug-15 4:59 PM View: | Evoke Pharma Inc (EVOK) | 18-Aug-15 | Market Sale | 11,836 | $7.02 | $83,088.70 | (1%) 1.06M to 1.05M | 62% |
| 06-May-15 5:26 PM View: | Tobira Therapeutics, Inc. (TBRA) | 04-May-15 | Purchase | 277,777 | $10.62 | $2,949,990.00 | 8% 3.28M to 3.55M | |
| 16-Apr-15 7:47 PM View: | Evoke Pharma Inc (EVOK) | 16-Apr-15 | Market Sale | 32,411 | $7.07 | $229,146.00 | (3%) 1.1M to 1.06M | 63% |
| 16-Apr-15 7:47 PM View: | Evoke Pharma Inc (EVOK) | 15-Apr-15 | Market Sale | 7,920 | $7.58 | $60,033.60 | (< 1%) 1.1M to 1.1M | 65% |
| 16-Apr-15 7:47 PM View: | Evoke Pharma Inc (EVOK) | 14-Apr-15 | Market Sale | 9,832 | $7.78 | $76,493.00 | (< 1%) 1.11M to 1.1M | 66% |
| 24-Mar-15 6:52 PM View: | Esperion Therapeutics, Inc. (ESPR) | 20-Mar-15 | Disposition (other) | 350,000 | -- | -- | (14%) 2.57M to 2.22M | |
| 26-Nov-14 11:06 AM View: | Evofem Biosciences, Inc. (EVFM) | 25-Nov-14 | Conversion | 2,921,060 | -- | -- | 100% 0 to 2.92M | |
| 26-Nov-14 11:06 AM View: | Evofem Biosciences, Inc. (EVFM) | 25-Nov-14 | Payment of Exercise | 157,317 | $14.00 | $2,202,440.00 | (5%) 3.25M to 3.09M | |
| 26-Nov-14 11:06 AM View: | Evofem Biosciences, Inc. (EVFM) | 25-Nov-14 | Option Exercise | 257,895 | $8.54 | $2,202,420.00 | 9% 2.92M to 3.18M | |
| 26-Nov-14 11:06 AM View: | Evofem Biosciences, Inc. (EVFM) | 25-Nov-14 | Purchase | 70,000 | $14.00 | $980,000.00 | 2% 3.18M to 3.25M | |
| 21-Oct-14 12:15 PM View: | Esperion Therapeutics, Inc. (ESPR) | 21-Oct-14 | Private Purchase | 500,000 | $20.00 | $10,000,000.00 | 24% 2.07M to 2.57M | 10% |
| 21-Mar-14 6:41 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition | 2,972,680 | $14.00 | $41,617,500.00 | (100%) 2.97M to 0 | < 1% |
| 17-Mar-14 3:12 PM View: | Achaogen, Inc. (AKAO) | 17-Mar-14 | Conversion | 1,987,050 | -- | -- | 100% 0 to 1.99M | |
| 14-Feb-14 5:05 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 12-Feb-14 | Payment of Exercise | 765,532 | $14.00 | $10,717,400.00 | (20%) 3.74M to 2.97M | |
| 14-Feb-14 5:05 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 12-Feb-14 | Option Exercise | 1,367,020 | $7.84 | $10,717,400.00 | 58% 2.37M to 3.74M | |
| 19-Nov-13 6:53 PM View: | Tandem Diabetes Care Inc (TNDM) | 19-Nov-13 | Conversion | 3,189,060 | -- | -- | 100% 0 to 3.19M | |
| 30-Sep-13 5:28 PM View: | Evoke Pharma Inc (EVOK) | 30-Sep-13 | Conversion | 1,114,330 | -- | -- | 100% 0 to 1.11M | |
| 02-Jul-13 4:55 PM View: | Esperion Therapeutics, Inc. (ESPR) | 01-Jul-13 | Conversion | 1,786,010 | -- | -- | 100% 0 to 1.79M | |
| 02-Jul-13 4:55 PM View: | Esperion Therapeutics, Inc. (ESPR) | 01-Jul-13 | Purchase | 280,923 | $14.00 | $3,932,920.00 | 16% 1.79M to 2.07M | |
| 05-Jun-13 5:50 PM View: | Clovis Oncology, Inc. (CLVS) | 04-Jun-13 | Market Sale | 159,192 | $64.58 | $10,280,600.00 | (6%) 2.74M to 2.58M | 92% |
| 17-Apr-13 5:27 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 15-Apr-13 | Market Sale (Planned) | 23,210 | $6.62 | $153,650.00 | (< 1%) 2.39M to 2.37M | (19%) |
| 10-Apr-13 4:49 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 10-Apr-13 | Market Sale (Planned) | 1,567 | $6.72 | $10,530.20 | (< 1%) 2.4M to 2.39M | (17%) |
| 10-Apr-13 4:49 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 09-Apr-13 | Market Sale (Planned) | 11,386 | $6.71 | $76,400.10 | (< 1%) 2.41M to 2.4M | (17%) |
| 10-Apr-13 4:49 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 08-Apr-13 | Market Sale (Planned) | 12,217 | $6.52 | $79,654.80 | (< 1%) 2.42M to 2.41M | (21%) |
| 22-Mar-13 8:28 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 21-Mar-13 | Market Sale (Planned) | 4,374 | $5.35 | $23,400.90 | (< 1%) 2.42M to 2.42M | (47%) |
| 21-Mar-13 4:58 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 20-Mar-13 | Market Sale (Planned) | 5,510 | $5.22 | $28,762.20 | (< 1%) 2.43M to 2.42M | (51%) |
| 21-Mar-13 4:58 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-13 | Market Sale (Planned) | 7,925 | $5.19 | $41,130.80 | (< 1%) 2.44M to 2.43M | (52%) |
| 19-Mar-13 4:34 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 18-Mar-13 | Market Sale (Planned) | 8,020 | $5.16 | $41,383.20 | (< 1%) 2.45M to 2.44M | (53%) |
| 19-Mar-13 4:34 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 15-Mar-13 | Market Sale (Planned) | 9,636 | $5.28 | $50,878.10 | (< 1%) 2.46M to 2.45M | (49%) |
| 15-Mar-13 4:55 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 14-Mar-13 | Market Sale (Planned) | 5,020 | $5.36 | $26,907.20 | (< 1%) 2.46M to 2.46M | (47%) |
| 15-Mar-13 4:55 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 13-Mar-13 | Market Sale (Planned) | 7,733 | $5.40 | $41,758.20 | (< 1%) 2.47M to 2.46M | (46%) |
| 13-Mar-13 8:33 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 12-Mar-13 | Market Sale (Planned) | 6,346 | $5.38 | $34,141.50 | (< 1%) 2.47M to 2.47M | (46%) |
| 13-Mar-13 8:33 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 11-Mar-13 | Market Sale (Planned) | 4,118 | $5.34 | $21,990.10 | (< 1%) 2.48M to 2.47M | (48%) |
| 11-Mar-13 6:29 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 08-Mar-13 | Market Sale (Planned) | 5,154 | $5.32 | $27,419.30 | (< 1%) 2.48M to 2.48M | (48%) |
| 11-Mar-13 6:29 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 07-Mar-13 | Market Sale (Planned) | 12,701 | $5.22 | $66,299.20 | (< 1%) 2.5M to 2.48M | (51%) |
| 07-Mar-13 6:19 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 06-Mar-13 | Market Sale (Planned) | 3,839 | $5.06 | $19,425.30 | (< 1%) 2.5M to 2.5M | (56%) |
| 06-Mar-13 6:35 PM View: | Clovis Oncology, Inc. (CLVS) | 06-Mar-13 | Market Sale | 98,349 | $24.51 | $2,410,530.00 | (3%) 2.84M to 2.74M | 80% |